To hear GSK CEO Emma Walmsley tell it, the third quarter presented “some challenges” for the drugmaker. | To hear GSK CEO ...

British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug.

the drugmaker’s senior vice president of oncology global product strategy. Enter: “Your Cancer Is Our Challenge,” a new ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

GSK's severe asthma therapy Nucala could ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...

The Federal Government is advancing its commitment to ensure a self-sustaining healthcare system by collaborating with ...

GSK's shares are falling 4% in premarket trading Wednesday after the British pharma giant posted lower-than-estimated quarterly sales and lowered its projection for vaccine sales ...

GlaxoSmithKline (GSK) Company Description: In the pharmaceutical industry ... as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain ...

Pharmaceutical and agricultural companies are among the industry groups pushing against a proposed levy on their returns from ...